JENNIFER RIVERS: Open Payments
NPI 1205816311 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 21 payments from 18 companies in 2025. Trend: 2023 $47 · 2024 $683 · 2025 $702
Food & beverage: $682Education: $20
| Company | Payments | Amount |
|---|---|---|
| DePuy Synthes Sales Inc. | 2 | $237 |
| Amgen Inc. | 2 | $56 |
| Novo Nordisk Inc | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 1 | $49 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Calliditas Therapeutics US Inc. | 1 | $29 |
| Aurinia Pharma U.S., Inc. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
Products named: EMBOTRAP, TAVNEOS, Ozempic, Vanrafia, ACTHAR, Kerendia, TARPEYO, LUPKYNIS.
Industry payments across CT — which companies pay providers there.
